We are international
Donate
TEXT SIZE   

Call the IMF Hotline. We are here for you. The IMF Office is open from 9:00 - 5:00 PT on Monday-Friday.

If you have a question, call the IMF Hotline at (800) 452-CURE (800-452-2873) in the US and Canada. The hotline is open from 9:00 - 4:00 PT Monday - Friday. Elsewhere call (818) 487-7455. You can also contact us via the web.
IMF - Home Page
previous     next      view all

Watch the webcast of the IMWG Conference Series "Making Sense of Treatment"

IMWG Myeloma Experts debate the latest trends in treatment
December 9, 2013
New Orleans, Louisiana, USA


IMF Holiday Store
Looking for something special to give your friends and family this holiday season? Check out the items in our holiday store. Your purcheses support the programs of the IMF. But order early! Many of the items are custom made, so the earlier you order the better!

View the IMF’s Multiple Myeloma Journalists’ Workshop and Webcast from ASH 2013 in New Orleans.
Panelists will discuss the progress that led to TODAY and the promise that will guide TOMORROW
Panelists: • Brian Durie, MD, International Myeloma Foundation Chairman and Co-founder • María-Victoria Mateos, MD, PhD, University Hospital of Salamanca, Spain • Joseph Mikhael, MD, Mayo Clinic, Scottsdale, Arizona

Hear the patient perspective from: • Joseph Tariman, PhD, APRN, IMF Nurse Leadership Board & Northwestern University Myeloma Program, Chicago, Illinois • Long-term myeloma survivors and advocate


The International Myeloma Foundation announces partnership with Onyx Pharmaceuticals to support Black Swan Research Initiative®

- Black Swan Research Initiative (BSRI®) Goal is Improving Treatment Options for Myeloma Patients 

- Onyx Partnership to Support Significant Research Initiative


Webcast of the "Critical Issues Need Answers: Providing Best Options for Myeloma Treatment in 2013" conference at ASH 2013

Friday, Dec. 6, 2013
1:30pm ET/12:30pm CT/10:30am PT
Ernest N. Morial Convention Center
New Orleans, Louisiana


Latest Myeloma Research, Live IMF Webcasts from American Society of Hematology Meeting

The International Myeloma Foundation says findings to be presented at this year's annual ASH meeting shed new light on when, how long and how much to treat myeloma patients.

–More Than 800 Myeloma Studies Will Be Featured at the 55th Annual Meeting of the American Society of Hematology (ASH)
–The IMF Will Present Several Educational and Informational Programs, and Update the Status of Its Groundbreaking Black Swan Research Initiative® to Find a Cure


Follow the IMF Social Media Team at ASH 2013 #ASH13IMF
Tune in as the IMF brings myeloma support group leaders and patients to New Orleans for the 55th annual meeting of the American Society of Hematology (ASH), an exciting convergence of 20,000 health care professionals from around the world. Start following the IMF ASH team members now on social media as they ramp up to share the latest clinical updates in myeloma research, therapies, and practice strategies via Twitter (#ASH13IMF), Facebook, blogs and videos.

Your help is urgently needed for Canadians living with myeloma
We kindly request your help for Canadians living with myeloma. Myeloma Canada, an international affiliated partner of the IMF, is participating in a Canadian government funding review process for the treatment of myeloma with pomalidomide (Pomalyst®) and needs our help.

It's Giving Tuesday!
This year, the International Myeloma Foundation proudly joins thousands of charities around the world in supporting Giving Tuesday - a day for us all to remember to give back. Support the IMF on December 3rd with your tribute gift and send someone you love one of three special edition holiday e-cards.

Health Reform and You: Navigating the Health Insurance Marketplaces
Experts discuss everything you need to know to apply for health insurance coverage through the new health insurance marketplaces plus questions that ALL myeloma patients should ask when searching for a new insurance plan. Learn where to apply, who can help, and what to keep in mind as a myeloma patient. The speakers will provide a broad national overview of these policies, and give you resources to learn more about what is happening in your state.

previous     next      view all